PPT-He et al., Supplemental Figure 4

T β RI T β RII T β RI protein fold change WT PEDF T β RII protein fold change WT PEDF T β RI mRNA fold change WT PEDF T. Linda Beebe. June 2, 2011. SSP June 2, 2011. SSP June 2, 2011. Collision of 2 Worlds. SSP June 2, 2011. Explosion of─. . Research. . Data. . Accrued Knowledge. Increased Requirements. A. Academic/Research Program. Extent of Lung Resection. No. of Subject. Event. Censored. Median Survival (95% CI). 60 mo Survival. Lobectomy. 1778. 616 (35%). 1162 (65%). NA (99.6, NA). 73.6% (71.4%, 75.6%). Figure . S1. . . (A) . Schematic shows the three KREN1, KREN2, and KREN3 ~20S editosomes, and their protein interactions identified by yeast two-hybrid and co-expression studies (dashed lines) (Schnaufer et al. 2003; Schnaufer et al. 2010; Mehta et al. 2015). (B-D) Networks show detailed editosome architecture revealed by cross-linking and mass spectrometry (CXMS) (McDermott et al. 2016). Network edge widths are proportional to the number of interlinks observed between two proteins. All previously described interactions between editosome proteins were found in our cross-linking data. . 2012). 345,641 diverse . protein . families. Multiple. sequences. 2. 47. ,. 437. with . at least . 3. homologous. . sequences. Full length. proteins. 224. ,4. 09. . where majority of sequences have . children . aged 2–5 years . with employer-sponsored insurance receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2014. SUPPLEMENTAL FIGURE 2.. . Percentage of . CD44. GM130. CD40. MSCs. EVs. B. C. Supplemental Figure 1. Supplemental Figure 2. Supplemental Figure 3 . Supplemental Figure 4. A. B. A. B. C. Supplemental Figure 5. D. SSC. CD206. CD206. 25.7%. 14%. DMSs . and dietary intake and lifestyle factors at . exam 5 . for . all participants (n=1880). . -log10 (P value). 60. 50. 40. 30. 20. 10. 132 Nutrients/Bioactive . 129 Food group1 (FFD). 29 Food group2 (FG5Serv). fpkm. ). PD-L1 (. fpkm. ). CD8 (. fpkm. ). Iba1 (. fpkm. ). p. < 0.001. p. < 0.001. p. < 0.001. p. < 0.001. GM-CSF. GM-CSF. GM-CSF. GM-CSF. Supplemental Figure 1. Gene expression analysis in breast cancer cases from TCGA database. Gene expression levels of CD8, Iba1, PD-L1, and PD-L2 in breast cancer were compared between the cases with and without GM-CSF expression. The Mann-Whitney . 1. 5. 10. 30. 50. 100. SP600125. 0,1. 1. 2. 5. 10. 20. ER-27319. 1. 5. 10. 30. 50. 100. Inhibitors concentration (µM). A. B. Supplemental Figure 1: B cell survival (A) . B cells were pre-treated with kinase inhibitors (GF109203 (PKC. GSE47460_GPL14550 . GSE47460_GPL6480 . Supplemental Figure 2. Megakaryocyte score. Platelet score. FVC. DLCO. A. B. Megakaryocyte score. Platelet score. FVC. DLCO. r = -0.09331, p = 0.5237. r = 0.07781, p = 0.6721. 3. Table 1. . Significance level of comparison of absolute sweat rates for all regions measured at exercise intensity 1, uncorrected for multiple comparisons. . Supplemental Digital Content . 3. Table . suboptimally. positioned. There was a normal . cardiothymic. silhouette. The lungs were clear. Air in scattered loops of . nondilated. small and large bowel, within all four quadrants of the abdomen.. A.. B.. Supplemental Figure 3. Control. α-synuclein. Vehicle. Nicotine. A.. B.. C.. D.. No RNAi. SV2L1 KD. SV2L2 KD. children . aged 2–5 years . in Medicaid receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2011. 0.45-1.40%. 1.41-1.70%. 1.71-2.05%. 2.06-3.38%. SUPPLEMENTAL FIGURE 5. .